glutathione parkinson's study Central nervous system uptake of intranasal in disease G6PD deficiency triggers dopamine loss

2001;280(2):G1076G1082

Glutathione, specifically in its reduced form as a sodium salt, is the focus of this clinical trial

It is integrative and multisystemic

This is the first evidence, to our knowledge, that this protein is glutathionylated and this is most likely because of the very low concentration in the secretome which is below the limit of detection for most proteomic methods

Despite advances in therapeutic technologies, the lack of humanized experimental models of Fabry disease has limited the development of new therapies to cure the disease

In recent years, Semaglutide has also gained FDA approval for weight loss under the name Wegovy